We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
2 hedge funds and large institutions have $2.63K invested in Evelo Biosciences, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
93% less funds holding
Funds holding: 29 → 2 (-27)
93% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 29
100% less capital invested
Capital invested by funds: $52M → $2.63K (-$52M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
2
Holders Change
-27
Holders Change %
-93.1%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$53.2K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$11.3K |
Top Sellers
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$31.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.59M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$5.69M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.4M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.04M |